India likely to delay COVAX vaccine supplies for March, April, says UNICEF

Krishna N. Das, Reuters

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2021/news/03/05/20210304-vaccine-astrazeneca-arrival-4.jpg"/><figcaption>Some 487,200 doses of AstraZeneca COVID-19 vaccines from COVAX facility arrived at the Villamor Air Base in Pasay City on March 4, 2021. <em>PCOO-OGMPA handout/file</em></figcaption></figure></div><p>NEW DELHI - India will likely delay deliveries of AstraZeneca coronavirus vaccine doses to the GAVI/WHO-backed COVAX facility for March and April, the program&#x27;s procurement and distributing partner UNICEF told Reuters early on Thursday.</p><p>&quot;We understand that deliveries of COVID-19 vaccines to lower-income economies participating in the COVAX Facility will likely face delays following a setback in securing export licenses for further doses of COVID-19 vaccines produced by the Serum Institute of India (SII), expected to be shipped in March and April,&quot; UNICEF said in an email.</p><p>&quot;COVAX is in talks with the Government of India with a view to ensuring deliveries as quickly as possible.&quot;</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/03/11/21/unicef-chief-1-billion-more-needed-for-covax-covid-19-vaccine-rollout">UNICEF chief: $1 billion more needed for COVAX COVID-19 vaccine rollout</a></li></ul><p>Reuters reported on Wednesday that India had put a temporary hold on all major exports of the AstraZeneca shot made by SII, the world’s biggest vaccine-maker, to meet domestic demand as infections rise.</p><p>UNICEF also said that COVAX participant countries have also been told about lower-than-expected supplies of AstraZeneca doses made in South Korea for March.</p><p>&quot;In line with the challenges of the current global supply environment, this is due to challenges the company faces in rapidly scaling up supply and optimizing production processes for these early deliveries,&quot; UNICEF said. </p><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=1611054" width="100%"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div>

<p>India will likely delay deliveries of AstraZeneca coronavirus vaccine doses to the GAVI/WHO-backed COVAX facility for March and April, the program's procurement and distributing partner UNICEF told Reuters early on Thursday.</p>

India will likely delay deliveries of AstraZeneca coronavirus vaccine doses to the GAVI/WHO-backed COVAX facility for March and April, the program's procurement and distributing partner UNICEF told Reuters early on Thursday.

India likely to delay COVAX vaccine supplies for March, April, says UNICEF | ABS-CBN

Halalan 2025

Entertainment

News

Metro.Style

Lifestyle

Sports

More

Traffic

Horoscope

Overseas

India likely to delay COVAX vaccine supplies for March, April, says UNICEF

India likely to delay COVAX vaccine supplies for March, April, says UNICEF

Krishna N. Das,

Reuters

Published Mar 25, 2021 07:47 AM PHT

Read More:

ANC

India

COVAX Facility

AstraZeneca

COVID-19 vaccine

UNICEF

COVID-19 vaccine supply

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.